ivabradine has been researched along with Hypertension, Pulmonary in 9 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 7 (77.78) | 24.3611 |
| 2020's | 2 (22.22) | 2.80 |
| Authors | Studies |
|---|---|
| Arrotti, S; Boriani, G; Coppi, F; Monopoli, DE; Rossi, R; Sgura, FA; Talarico, M | 1 |
| Kojonazarov, B | 1 |
| Brunetti, ND; Correale, M; Di Biase, M; Monaco, I; Zicchino, S | 1 |
| Bijnens, B; Friedberg, MK; Gomez, O; Honjo, O; Ishii, R; Okumura, K; Sun, M | 1 |
| Brunetti, ND; Correale, M; di Biase, M; Ferraretti, A; Ieva, R; Montrone, D; Totaro, A | 1 |
| Biase, MD; Brunetti, ND; Correale, M; Montrone, D | 1 |
| Akhmetzianova, ÉKh; Bakirov, AB; Bogoroditskaia, OA; Gaĭnitdinova, VV; Timershina, IR | 1 |
| Brunetti, ND; Correale, M; Di Biase, M; Ieva, R; Montrone, D | 2 |
1 trial(s) available for ivabradine and Hypertension, Pulmonary
| Article | Year |
|---|---|
[Effect of ivabradine on pulmonary hypertension in chronic obstructive pulmonary disease].
Topics: Benzazepines; Cyclic Nucleotide-Gated Cation Channels; Exercise Tolerance; Female; Heart Rate; Humans; Hypertension, Pulmonary; Ivabradine; Male; Middle Aged; Monitoring, Physiologic; Myocardial Contraction; Pulmonary Disease, Chronic Obstructive; Severity of Illness Index; Spirometry; Treatment Outcome | 2012 |
8 other study(ies) available for ivabradine and Hypertension, Pulmonary
| Article | Year |
|---|---|
Effects of Ivabradine on Right Ventricular Systolic Function in Patients With Chronic Obstructive Pulmonary Disease and Cor Pulmonale.
Topics: Aged; Humans; Hypertension, Pulmonary; Ivabradine; Male; Middle Aged; Prospective Studies; Pulmonary Disease, Chronic Obstructive; Pulmonary Heart Disease; Quality of Life; Tachycardia; Ventricular Function, Right | 2023 |
Heart Rate Reduction by Ivabradine: Slowly but Surely?
Topics: Fibrosis; Heart Rate; Humans; Hypertension, Pulmonary; Ivabradine; Ventricular Function, Right | 2020 |
Angiotensin-converting enzyme inhibitors, angiotensin II receptors antagonists, beta-blockers and ivabradine as supportive therapy in pulmonary hypertension: Drug safety and tolerability.
Topics: Adrenergic beta-Antagonists; Aged; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Benzazepines; Drug Therapy, Combination; Drug-Related Side Effects and Adverse Reactions; Female; Humans; Hypertension, Pulmonary; Ivabradine; Male; Middle Aged; Patient Readmission | 2017 |
Heart rate reduction improves biventricular function and interactions in experimental pulmonary hypertension.
Topics: Adrenergic beta-Antagonists; Animals; Anti-Arrhythmia Agents; Carvedilol; Disease Models, Animal; Drug Therapy, Combination; Heart Rate; Hypertension, Pulmonary; Ivabradine; Male; Monocrotaline; Rats, Sprague-Dawley; Recovery of Function; Time Factors; Ventricular Function, Left; Ventricular Function, Right | 2018 |
Functional improvement in pulmonary arterial hypertension patients treated with ivabradine.
Topics: Aged; Benzazepines; Female; Heart Rate; Humans; Hypertension, Pulmonary; Ivabradine; Male; Middle Aged; Recovery of Function; Treatment Outcome | 2014 |
Safe and well-tolerated treatment with ivabradine in systemic sclerosis affected by pulmonary hypertension.
Topics: Anti-Arrhythmia Agents; Antihypertensive Agents; Benzazepines; Cardiac Catheterization; Drug Therapy, Combination; Echocardiography, Doppler; Exercise Test; Exercise Tolerance; Familial Primary Pulmonary Hypertension; Female; Heart Rate; Humans; Hypertension, Pulmonary; Ivabradine; Middle Aged; Pulmonary Artery; Pulmonary Wedge Pressure; Scleroderma, Systemic; Time Factors; Treatment Outcome | 2012 |
Ivabradine in systemic sclerosis related pulmonary arterial hypertension.
Topics: Aged; Benzazepines; Familial Primary Pulmonary Hypertension; Female; Heart Failure; Humans; Hypertension, Pulmonary; Ivabradine; Middle Aged; Scleroderma, Systemic; Treatment Outcome | 2012 |
Ivabradine in pulmonary arterial hypertension: can we delay the need for parenteral prostanoid therapy?
Topics: Aged; Antihypertensive Agents; Arterial Pressure; Benzazepines; Drug Therapy, Combination; Familial Primary Pulmonary Hypertension; Female; Humans; Hypertension, Pulmonary; Infusions, Parenteral; Ivabradine; Male; Middle Aged; Phosphodiesterase 5 Inhibitors; Piperazines; Prostaglandins; Pulmonary Artery; Purines; Sildenafil Citrate; Sulfones; Treatment Outcome; Vasodilator Agents | 2013 |